Bariatric surgery was associated with improved survival and appeared cost-effective over 10 years among patients with obesity and compensated cirrhosis, according to an analysis published in JAMA ...

Cirrhosis progresses in stages, from a compensated phase with few symptoms to a decompensated phase with serious ...

The U.S. FDA granted breakthrough device designation to Mursla Bio Ltd.'s Evoliver. The biopsy blood test uses extracellular vesicles to survey hepatocellular carcinoma in high-risk cirrhotic patients ...

Hepatorenal syndrome, acute tubular necrosis, and pneumonia may increase the need for renal replacement therapy in patients with cirrhosis and acute kidney injury. The presence of hepatorenal syndrome ...

Patients with cirrhosis and obesity who undergo bariatric surgery see survival benefits over 10 years that make the surgery cost-effective compared with people who only receive a lifestyle ...

In this study, we present a model based on the TGF-β and associated immune pathways for the HCC stratification in cirrhotic patients that incorporates biologically relevant proteins to capture ongoing ...

Purpose Published evidence on the incidence and predictors of venous thromboembolism (VTE) in patients with cirrhosis of the liver is reviewed. Summary The frequently observed phenomenon of ...

This project presents an interactive R Shiny dashboard built for analyzing and visualizing a real-world dataset on patients diagnosed with liver cirrhosis. The goal is to extract meaningful insights ...

This project presents an interactive R Shiny dashboard built for analyzing and visualizing a real-world dataset on patients diagnosed with liver cirrhosis. The goal is to extract meaningful insights ...